Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study.

Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani C, Coffetti N, Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G; Italian Federation of Anticoagulation Clinics.

Int J Cardiol. 2018 Sep 15;267:68-73. doi: 10.1016/j.ijcard.2018.04.042.

PMID:
29957264
2.

Bone matrix development in steroid-induced osteoporosis is associated with a consistently reduced fibrillar stiffness linked to altered bone mineral quality.

Xi L, De Falco P, Barbieri E, Karunaratne A, Bentley L, Esapa CT, Terrill NJ, Brown SDM, Cox RD, Davis GR, Pugno NM, Thakker RV, Gupta HS.

Acta Biomater. 2018 Aug;76:295-307. doi: 10.1016/j.actbio.2018.05.053. Epub 2018 Jun 15.

3.

Influence of environmental variables on saxitoxin yields by Cylindrospermopsis raciborskii in a mesotrophic subtropical reservoir.

Casali SP, Dos Santos ACA, de Falco PB, Calijuri MDC.

J Water Health. 2017 Aug;15(4):509-518. doi: 10.2166/wh.2017.266.

PMID:
28771148
4.

Towards in situ determination of 3D strain and reorientation in the interpenetrating nanofibre networks of cuticle.

Zhang Y, De Falco P, Wang Y, Barbieri E, Paris O, Terrill NJ, Falkenberg G, Pugno NM, Gupta HS.

Nanoscale. 2017 Aug 10;9(31):11249-11260. doi: 10.1039/c7nr02139a.

PMID:
28753215
5.

Citizen science participation in research in the environmental sciences: key factors related to projects' success and longevity.

Cunha DGF, Marques JF, Resende JC, Falco PB, Souza CM, Loiselle SA.

An Acad Bras Cienc. 2017;89(3 Suppl):2229-2245. doi: 10.1590/0001-3765201720160548. Epub 2017 Jun 29. Review.

6.

Endolymphatic hydrops in idiopathic intracranial hypertension: prevalence and clinical outcome after lumbar puncture. Preliminary data.

Ranieri A, Cavaliere M, Sicignano S, Falco P, Cautiero F, De Simone R.

Neurol Sci. 2017 May;38(Suppl 1):193-196. doi: 10.1007/s10072-017-2895-8.

PMID:
28527079
7.

The contribution of volunteer-based monitoring data to the assessment of harmful phytoplankton blooms in Brazilian urban streams.

Cunha DGF, Casali SP, de Falco PB, Thornhill I, Loiselle SA.

Sci Total Environ. 2017 Apr 15;584-585:586-594. doi: 10.1016/j.scitotenv.2017.01.080. Epub 2017 Feb 4.

PMID:
28169029
8.

Iron supplement tablet embedded in the oral cavity mimicking neoplasm: a case report.

Corlianò F, Falco P, Cambi J, Brindisi L.

J Korean Assoc Oral Maxillofac Surg. 2016 Apr;42(2):111-4. doi: 10.5125/jkaoms.2016.42.2.111. Epub 2016 Apr 27.

9.

Engaging stakeholders to design a comparative effectiveness trial in children with uncontrolled asthma.

Erwin K, Martin MA, Flippin T, Norell S, Shadlyn A, Yang J, Falco P, Rivera J, Ignoffo S, Kumar R, Margellos-Anast H, McDermott M, McMahon K, Mosnaim G, Nyenhuis SM, Press VG, Ramsay JE, Soyemi K, Thompson TM, Krishnan JA.

J Comp Eff Res. 2016 Jan;5(1):17-30. doi: 10.2217/cer.15.52. Epub 2015 Dec 21. Erratum in: J Comp Eff Res. 2016 Mar;5(2):228.

10.

Trophic State Evolution and Nutrient Trapping Capacity in a Transboundary Subtropical Reservoir: A 25-Year Study.

Cunha DG, Benassi SF, de Falco PB, Calijuri Mdo C.

Environ Manage. 2016 Mar;57(3):649-59. doi: 10.1007/s00267-015-0633-7. Epub 2015 Nov 24.

PMID:
26604008
11.

Femicide in Italy: national scenario and presentation of four cases.

Bonanni E, Maiese A, Gitto L, Falco P, Maiese A, Bolino G.

Med Leg J. 2014 Mar;82(1):32-7. doi: 10.1177/0025817213510250.

PMID:
24619844
12.

Cost of illness in patients with multiple myeloma in Italy: the CoMiM study.

Petrucci MT, Calabrese E, Levi A, Federico V, Ceccolini M, Rizzi R, Gozzetti A, Falco P, Lazzaro C, Martelli E, Boccadoro M, Lauria F, Liso V, Cavo M, Foa R.

Tumori. 2013 Jul-Aug;99(4):e193-202. doi: 10.1700/1361.15125.

PMID:
24326862
13.

Arrow-arrow correlations for the six-vertex model.

Falco P.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Sep;88(3):030103. Epub 2013 Sep 16.

PMID:
24125201
14.

Role of 0.4 % glyceryl trinitrate ointment after stapled trans-anal rectal resection for obstructed defecation syndrome: a prospective, randomized trial.

Izzo D, Brillantino A, Iacobellis F, Falco P, Renzi A, Rea R.

Int J Colorectal Dis. 2014 Jan;29(1):105-10. doi: 10.1007/s00384-013-1758-x. Epub 2013 Aug 14.

PMID:
23943282
15.

Interacting fermions picture for dimer models.

Falco P.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jun;87(6):060101. Epub 2013 Jun 6.

PMID:
23848610
16.

Laparocopic ventral hernia repair with primary transparietal closure of the hernial defect.

Rea R, Falco P, Izzo D, Leongito M, Amato B.

BMC Surg. 2012;12 Suppl 1:S33. doi: 10.1186/1471-2482-12-S1-S33. Epub 2012 Nov 15.

17.

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients.

Falco P, Cavallo F, Larocca A, Rossi D, Guglielmelli T, Rocci A, Grasso M, Siez ML, De Paoli L, Oliva S, Molica S, Mina R, Gay F, Benevolo G, Musto P, Omedè P, Freilone R, Bringhen S, Carella AM, Gaidano G, Boccadoro M, Palumbo A.

Leukemia. 2013 Mar;27(3):695-701. doi: 10.1038/leu.2012.271. Epub 2012 Sep 21.

PMID:
22996335
18.

A Device for the Functional Evaluation of the VOR in Clinical Settings.

Ramat S, Colnaghi S, Boehler A, Astore S, Falco P, Mandalà M, Nuti D, Colagiorgio P, Versino M.

Front Neurol. 2012 Mar 23;3:39. doi: 10.3389/fneur.2012.00039. eCollection 2012.

19.

Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.

Falco P, Levis A, Stacchini A, Ciriello MM, Geuna M, Notari P, Omedè P, Pautasso M, Prato G, Strola G, Gioia D, Bonferroni M, Cametti G, Ferrero D, Freilone R, Gaidano G, Marinone C, Marmont F, Pollio B, Salvi F, Saglio G, Girotto M; Piedmont MDS Registry--Italy.

Eur J Haematol. 2011 Nov;87(5):409-18. doi: 10.1111/j.1600-0609.2011.01676.x. Epub 2011 Aug 11.

PMID:
21711395
20.

Biogeochemical processes and the diversity of Nhecolândia lakes, Brazil.

Almeida TI, Calijuri Mdo C, Falco PB, Casali SP, Kupriyanova E, Paranhos Filho AC, Sigolo JB, Bertolo RA.

An Acad Bras Cienc. 2011 Jun;83(2):391-407.

21.

A novel microdeletion in the IGF2/H19 imprinting centre region defines a recurrent mutation mechanism in familial Beckwith-Wiedemann syndrome.

De Crescenzo A, Coppola F, Falco P, Bernardo I, Ausanio G, Cerrato F, Falco L, Riccio A.

Eur J Med Genet. 2011 Jul-Aug;54(4):e451-4. doi: 10.1016/j.ejmg.2011.04.009. Epub 2011 May 4.

22.

Megasporogenesis and programmed cell death in Tillandsia (Bromeliaceae).

Papini A, Mosti S, Milocani E, Tani G, Di Falco P, Brighigna L.

Protoplasma. 2011 Oct;248(4):651-62. doi: 10.1007/s00709-010-0221-x. Epub 2010 Oct 27.

PMID:
20978809
23.

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.

Gay F, Vincent Rajkumar S, Falco P, Kumar S, Dispenzieri A, Petrucci MT, Gertz MA, Boccadoro M, Keith Stewart A, Palumbo A.

Eur J Haematol. 2010 Sep;85(3):200-8. doi: 10.1111/j.1600-0609.2010.01469.x. Epub 2010 May 8.

PMID:
20477865
24.

Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma.

Palumbo A, Larocca A, Falco P, Sanpaolo G, Falcone AP, Federico V, Canepa L, Crugnola M, Genuardi M, Magarotto V, Petrucci MT, Boccadoro M.

Leukemia. 2010 May;24(5):1037-42. doi: 10.1038/leu.2010.58. Epub 2010 Apr 8.

PMID:
20376079
25.

Universal relations for nonsolvable statistical models.

Benfatto G, Falco P, Mastropietro V.

Phys Rev Lett. 2010 Feb 19;104(7):075701. Epub 2010 Feb 16.

PMID:
20366897
26.

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

Palumbo A, Gay F, Falco P, Crippa C, Montefusco V, Patriarca F, Rossini F, Caltagirone S, Benevolo G, Pescosta N, Guglielmelli T, Bringhen S, Offidani M, Giuliani N, Petrucci MT, Musto P, Liberati AM, Rossi G, Corradini P, Boccadoro M.

J Clin Oncol. 2010 Feb 10;28(5):800-7. doi: 10.1200/JCO.2009.22.7561. Epub 2010 Jan 4. Erratum in: J Clin Oncol. 2010 May 1;28(13):2314.

PMID:
20048187
27.

Prenatal diagnosis and outcome of partial agenesis and hypoplasia of the corpus callosum.

Ghi T, Carletti A, Contro E, Cera E, Falco P, Tagliavini G, Michelacci L, Tani G, Youssef A, Bonasoni P, Rizzo N, Pelusi G, Pilu G.

Ultrasound Obstet Gynecol. 2010 Jan;35(1):35-41. doi: 10.1002/uog.7489.

28.

Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results.

Palumbo A, Falco P, Falcone A, Benevolo G, Canepa L, Gay F, Larocca A, Magarotto V, Gozzetti A, Luraschi A, Morabito F, Nozza A, Knight RD, Zeldis JB, Boccadoro M, Petrucci MT.

Clin Lymphoma Myeloma. 2009 Apr;9(2):145-50. doi: 10.3816/CLM.2009.n.035.

PMID:
19406725
29.

Determination of ammonia and primary amine compounds and Kjeldahl nitrogen in water samples with a modified Roth's fluorimetric method.

Lloret SM, Andrés JV, Legua CM, Falcó PC.

Talanta. 2005 Feb 28;65(4):869-75. doi: 10.1016/j.talanta.2004.08.050.

PMID:
18969881
30.

Update on recent developments for patients with newly diagnosed multiple myeloma.

Palumbo A, Magarotto V, Gay F, Falco P, Bringhen S, Boccadoro M.

Ann N Y Acad Sci. 2008 Sep;1138:19-21. doi: 10.1196/annals.1414.004.

PMID:
18837878
31.

Lenalidomide and its role in the management of multiple myeloma.

Falco P, Cavallo F, Larocca A, Liberati AM, Musto P, Boccadoro M, Palumbo A.

Expert Rev Anticancer Ther. 2008 Jun;8(6):865-74. doi: 10.1586/14737140.8.6.865. Review.

PMID:
18533796
32.

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

Palumbo A, Bringhen S, Liberati AM, Caravita T, Falcone A, Callea V, Montanaro M, Ria R, Capaldi A, Zambello R, Benevolo G, Derudas D, Dore F, Cavallo F, Gay F, Falco P, Ciccone G, Musto P, Cavo M, Boccadoro M.

Blood. 2008 Oct 15;112(8):3107-14. doi: 10.1182/blood-2008-04-149427. Epub 2008 May 27.

33.

Treatment of newly diagnosed multiple myeloma.

Palumbo A, Magarotto V, Larocca A, Bringhen S, Falco P, Di Raimondo F, Baldini L, Boccadoro M.

Curr Hematol Malig Rep. 2008 Apr;3(2):107-14. doi: 10.1007/s11899-008-0016-8.

PMID:
20425454
34.

Efficacy of a haemostatic matrix for the management of bleeding in patients undergoing liver resection: results from 237 cases.

Izzo F, Di Giacomo R, Falco P, Piccirillo M, Iodice R, Orlando AP, Aprea P, Cremona F, Di Marzo M, Idà DN, Mastro AA, Curley SA.

Curr Med Res Opin. 2008 Apr;24(4):1011-5. doi: 10.1185/030079908X280392 . Epub 2008 Feb 19.

PMID:
18291065
35.

Thromboembolic events with lenalidomide-based therapy for multiple myeloma.

Menon SP, Rajkumar SV, Lacy M, Falco P, Palumbo A.

Cancer. 2008 Apr 1;112(7):1522-8. doi: 10.1002/cncr.23336.

36.

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.

Palumbo A, Falco P, Corradini P, Falcone A, Di Raimondo F, Giuliani N, Crippa C, Ciccone G, Omedè P, Ambrosini MT, Gay F, Bringhen S, Musto P, Foà R, Knight R, Zeldis JB, Boccadoro M, Petrucci MT; GIMEMA--Italian Multiple Myeloma Network.

J Clin Oncol. 2007 Oct 1;25(28):4459-65. Epub 2007 Sep 4.

PMID:
17785703
37.

Melphalan and its role in the management of patients with multiple myeloma.

Falco P, Bringhen S, Avonto I, Gay F, Morabito F, Boccadoro M, Palumbo A.

Expert Rev Anticancer Ther. 2007 Jul;7(7):945-57. Review.

PMID:
17627453
38.

Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.

Palumbo A, Bringhen S, Falco P, Cavallo F, Ambrosini MT, Avonto I, Gay F, Caravita T, Bruno B, Boccadoro M.

Cancer. 2007 Aug 15;110(4):824-9.

39.

Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.

Offidani M, Bringhen S, Corvatta L, Falco P, Marconi M, Avonto I, Piersantelli MN, Polloni C, Boccadoro M, Leoni P, Palumbo A.

Eur J Haematol. 2007 Apr;78(4):297-302. Epub 2007 Feb 5.

PMID:
17286608
40.

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma.

Palumbo A, Ambrosini MT, Benevolo G, Pregno P, Pescosta N, Callea V, Cangialosi C, Caravita T, Morabito F, Musto P, Bringhen S, Falco P, Avonto I, Cavallo F, Boccadoro M; Italian Multiple Myeloma Network; Gruppo Italiano Malattie Ematologicche dell'Adulto.

Blood. 2007 Apr 1;109(7):2767-72.

41.

Prenatal diagnosis of open and closed spina bifida.

Ghi T, Pilu G, Falco P, Segata M, Carletti A, Cocchi G, Santini D, Bonasoni P, Tani G, Rizzo N.

Ultrasound Obstet Gynecol. 2006 Dec;28(7):899-903.

42.

Intermediate-dose melphalan (100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma.

Palumbo A, Avonto I, Bruno B, Falcone A, Scalzulli PR, Ambrosini MT, Bringhen S, Gay F, Rus C, Cavallo F, Falco P, Massaia M, Musto P, Boccadoro M.

Clin Lymphoma Myeloma. 2006 May;6(6):475-7.

PMID:
16796778
43.

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.

Palumbo A, Bringhen S, Caravita T, Merla E, Capparella V, Callea V, Cangialosi C, Grasso M, Rossini F, Galli M, Catalano L, Zamagni E, Petrucci MT, De Stefano V, Ceccarelli M, Ambrosini MT, Avonto I, Falco P, Ciccone G, Liberati AM, Musto P, Boccadoro M; Italian Multiple Myeloma Network, GIMEMA.

Lancet. 2006 Mar 11;367(9513):825-31.

PMID:
16530576
44.

Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.

Palumbo A, Avonto I, Bruno B, Ambrosini MT, Bringhen S, Cavallo F, Falco P, Boccadoro M.

Eur J Haematol. 2006 Apr;76(4):273-7.

PMID:
16519697
45.

Thalidomide plus dexamethasone is an effective salvage regimen for myeloma patients relapsing after autologous transplant.

Palumbo A, Falco P, Ambrosini MT, Petrucci MT, Musto P, Caravita T, Pregno P, Bertola A, Cavallo F, Ciccone G, Boccadoro M.

Eur J Haematol. 2005 Nov;75(5):391-5.

PMID:
16191088
46.

Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.

Palumbo A, Bertola A, Musto P, Caravita T, Callea V, Nunzi M, Grasso M, Falco P, Cangialosi C, Boccadoro M.

Cancer. 2005 Oct 1;104(7):1428-33.

47.

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

Ladetto M, Vallet S, Trojan A, Dell'Aquila M, Monitillo L, Rosato R, Santo L, Drandi D, Bertola A, Falco P, Cavallo F, Ricca I, De Marco F, Mantoan B, Bode-Lesniewska B, Pagliano G, Francese R, Rocci A, Astolfi M, Compagno M, Mariani S, Godio L, Marino L, Ruggeri M, Omedè P, Palumbo A, Boccadoro M.

Blood. 2005 Jun 15;105(12):4784-91. Epub 2005 Feb 24.

48.

Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma.

Falco P, Bertola A, Bringhen S, Cavallo F, Boccadoro M, Palumbo A.

Hematol J. 2004;5(5):456-7. No abstract available.

PMID:
15448677
49.

Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma.

Palumbo A, Bertola A, Falco P, Rosato R, Cavallo F, Giaccone L, Bringhen S, Musto P, Pregno P, Caravita T, Ciccone G, Boccadoro M.

Hematol J. 2004;5(4):318-24.

PMID:
15297848
50.

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.

Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M, Lauta VM, Bergonzi C, Barbui A, Caravita T, Capaldi A, Pregno P, Guglielmelli T, Grasso M, Callea V, Bertola A, Cavallo F, Falco P, Rus C, Massaia M, Mandelli F, Carella AM, Pogliani E, Liberati AM, Dammacco F, Ciccone G, Boccadoro M.

Blood. 2004 Nov 15;104(10):3052-7. Epub 2004 Jul 20.

Supplemental Content

Support Center